Outcome measures for hereditary spastic paraplegia clinical trials: Learnings from an Australian HSP center

Affiliations

• ¹ Department of Clinical Genetics, Royal North Shore Hospital, NSW, Australia; Sydney Medical School, The University of Sydney, NSW, Australia; Department of Neurogenetics, Royal North Shore Hospital, NSW, Australia. Electronic address: Suefaye.siow@health.nsw.gov.au.
• ² Department of Neurology and Clinical Neurophysiology, Royal North Shore Hospital, NSW, Australia.
• ³ Sydney Medical School, The University of Sydney, NSW, Australia; Department of Neurogenetics, Royal North Shore Hospital, NSW, Australia; Neuroscience Research Australia, University of New South Wales, NSW, Australia.
• ⁴ Sydney Medical School, The University of Sydney, NSW, Australia; Department of Neurology and Clinical Neurophysiology, Royal North Shore Hospital, NSW, Australia.
• ⁵ Department of Neurogenetics, Royal North Shore Hospital, NSW, Australia; Neuroscience Research Australia, University of New South Wales, NSW, Australia; Faculty of Medicine and Health, University of New South Wales Sydney, NSW, Australia.
• ⁶ Sydney Medical School, The University of Sydney, NSW, Australia; Translational Neurogenomics Group, Genomics and Inherited Disease Program, Garvan Institute of Medical Research, NSW, Australia; Molecular Medicine Laboratory and Department of Neurology, Concord Repatriation General Hospital, NSW, Australia.